Financial Security Advisor »

Alnylam Pharmaceuticals shares owned by Financial Security Advisor

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Financial Security Advisor from 13F filings

Historical chart of Financial Security Advisor investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Financial Security Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Financial Security Advisor

Quarter filed Position value Share count Share price at filing
2026-06-30 $226k 750 301.03

More positions owned by Financial Security Advisor

Invesco NASDAQ 100 ETF Exchange Traded Fund (QQQM)
NEOS Enhanced Income Credit Select ETF Exchange Traded Fund
Invesco S&P 500 Pure Growth ETF Exchange Traded Fund (RPG)
Pacer US Cash Cows 100 ETF Exchange Traded Fund (COWZ)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)
Alphabet Inc Class A Common Stock (GOOGL)
State Street SPDR Portfolio S&P 60 Small Cap ETF Exchange Traded Fund (SPSM)
WisdomTree Floating Rate Treasury Fund Exchange Traded Fund (USFR)
Apple Common Stock (AAPL)
Janus Henderson AAA CLO ETF Exchange Traded Fund (JAAA)
Capital Group Growth ETF Exchange Traded Fund (CGGR)
Microsoft Corp Common Stock (MSFT)
JPMorgan Ultra-Short Income ETF Exchange Traded Fund (JPST)
NVIDIA Corp Common Stock (NVDA)
T. Rowe Price Capital Appreciation Equity ETF Exchange Traded Fund (TCAF)

View all positions for Financial Security Advisor

Top funds holding Alnylam Pharmaceuticals

FMR
BlackRock
Capital World Investors
Capital Research Global Investors
Vanguard Portfolio Management
Vanguard Capital Management
Invesco
State Street Corporation
Jpmorgan Chase & Co
Geode Capital Management
Baillie Gifford & Co
Norges Bank Investment Management
Wellington Management Company
Orbis Allan Gray
Dodge & Cox

View all funds holding Alnylam Pharmaceuticals